Evidence map›Paper›PMID 25692218›Full record

ArticleHuman vaccines & immunotherapeutics2015

Synchrony in serum antibody response to conserved proteins of Streptococcus pneumoniae in young children.

Dabin Ren, Anthony L Almudevar, Michael E Pichichero

Open access · bronzeAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Synchrony in serum antibody response to conserved proteins ofHuman vaccines & immunotherapeutics · 2020
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Panel 6: Vaccines.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2017
    Review
  10. Article
  11. Next generation protein based Streptococcus pneumoniae vaccines.Human vaccines & immunotherapeutics · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Dabin Rena Rochester General Hospital Research Institute ; Rochester , NY USA.
Anthony L Almudevar
Michael E Pichichero
Rochester General Hospital · USUniversity of Rochester Medical Center · US

Funding

NTHi Immunity in Young ChildrenR01DC008671 · NIDCD · UNIVERSITY OF ROCHESTER · PI PICHICHERO, MICHAEL E · 2007 to 2016
$5.8M
NIDCD NIH HHS R01 DC008671PHS HHS NIDCD R01 08671
6 · The paper itself

Abstract

Conserved Streptococcus pneumoniae (Spn) proteins are currently under investigation as vaccine candidates. We recently identified a subset of children prone to frequent acute otitis media (AOM) that we refer to as stringently-defined otitis prone (sOP). We investigated the synchrony of serum antibody responses against 5 Spn protein vaccine antigens, PhtD, LytB, PcpA, PhtE, and PlyD1 resulting from nasopharyngeal colonization and AOM in sOP children (49 observations) and non-otitis prone (NOP) children (771 observations). Changes in serum IgG and IgM were quantitated with ELISA. IgG antibody concentrations against PhtD, PcpA, and PlyD1 rose in synchrony in sOP and NOP children; that is, the proteins appeared equally and highly immunogenic in children at age 6 to 15 months and then leveled off in their rise at 15 to 25 months. In contrast, rises in concentrations to PhtE and LytB were significantly slower and had not peaked in children even at 25 months of age, consistent with lower immunogenicity. Serum IgM responses against PhtD and PlyD1 were in synchrony in children at age 6-25 months old. PcpA did not induce a significant increase of serum IgM response in children, suggesting that primary responses to PcpA occurred prior to children attaining age 6 months old. PhtD, PcpA, and Ply elicit a synchronous natural acquisition of serum antibody in young children suggesting that a trivalent Spn protein vaccine combining PhtD, PcpA, and PlyD1 would be less likely to display antigen competition when administered as a combination vaccine in young children.

Indexed as

Antibody FormationAge FactorsAntibodies, BacterialAntigens, BacterialBacterial ProteinsCarrier StateChild, PreschoolCohort StudiesEnzyme-Linked Immunosorbent AssayFemaleHumansImmunoglobulin GImmunoglobulin MInfantMaleOtitis MediaAntibodies, BacterialAntigens, BacterialBacterial ProteinsImmunoglobulin GImmunoglobulin MAOM, acute otitis mediaELISA, Enzyme-linked Immunosorbent AssayGAM, generalized additive modelGAMM, generalized additive mixed modelgeneralized additive mixed modelgeneralized additive modelLC, log10 ConcentrationLME, linear mixed effectsnasopharynxNOP, non-otitis proneNP, nasopharyngealOP, otitis pronePcpA, pneumococcal choline binding protein APCV, pneumococcal conjugate vaccinePhtD, pneumococcal histidine triad protein DPhtE, pneumococcal histidine triad protein EPlyD1, pneumolysin derivative 1Ply, pneumolysinpneumococcal choline binding protein Apneumococcal conjugate vaccinepneumococcal histidine triad protein Dpneumococcal histidine triad protein EpneumolysinsOP, stringently-defined otitis proneSpn, Streptococcus pneumoniaeStreptococcus pneumoniae

Identifiers

PMID25692218
PMCPMC4514345
OpenAlexW2000040330

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.